Exchange Traded Funds (ETFs) are a relatively new financial product that has experienced significant growth in the last few years. Leveraged, inverse, and inverse leveraged ETFs—new ETF structures that have become available over the last several years—have recently become the target of regulatory investigations and litigation. This article provides an introduction to ETFs in the context of recent regulatory problems and litigation.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...